证券日报网讯11月27日，富祥药业（300497）在互动平台回答投资者提问时表示，目前公司VC、FEC 产线稳健运行，生产经营正常，依据客户订单有序交付。 ...

格隆汇11月27日丨富祥药业(300497.SZ)在投资者互动平台表示，目前公司VC、FEC产线稳健运行，生 产经营正常，依据客户订单有序交付。 ...

富祥药业（300497.SZ）11月27日在投资者互动平台表示，目前公司VC、FEC产线稳健运行，生产经营 正常，依据客户订单有序交付。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问公司VC产线目前正常吗？是否有对外销售，目前 销售价格如何？ ...

【锂电池电解液概念震荡反弹 天际股份触及涨停】智通财经11月25日电，午后电解液概念震荡反弹， 天际股份触及涨停，多氟多、华盛锂电、丰元股份、安达科技、海科新源等跟涨。消息面上，根据上海 有色网11月24日数据，六氟磷酸锂及多种电解液溶剂价格全面上涨，其中EC出厂价日涨幅达8.33%， DMC出厂价日涨幅达6.93%，EMC、FEC、VC等产品也有不同程度的上涨。 转自：智通财经 ...

截至发稿，梁莉累计任职时间4年226天，现任基金资产总规模6431.4万元，任职期间最佳基金回报 19.43%， 任职期间最差基金回报-65.14%。 资料显示，江苏华盛锂电材料股份有限公司位于江苏扬子江国际化学工业园德盛路1号，成立日期1997 年8月4日，上市日期2022年7月13日，公司主营业务涉及专注于锂电池电解液添加剂的研发、生产和销 售。主营业务收入构成为：VC67.54%，FEC27.01%，其他5.44%。 天治研究驱动混合A（350009）成立日期2011年12月28日，最新规模2115.48万。今年以来收益3.92%， 同类排名6772/8136；近一年亏损1.58%，同类排名7881/8058；成立以来收益178.05%。 天治研究驱动混合A（350009）基金经理为梁莉。 从基金十大重仓股角度 11月25日，华盛锂电涨5.05%，截至发稿，报98.12元/股，成交9.55亿元，换手率8.50%，总市值156.50 亿元。 数据显示，天治基金旗下1只基金重仓华盛锂电。天治研究驱动混合A（350009）三季度持有股数1.14万 股，占基金净值比例为2.26%，位居第二大重仓股。根据测算，今 ...

Core Points - The stock price of Huasheng Lithium Electric increased by 2.21% to 115.50 CNY per share, with a market capitalization of 18.422 billion CNY [1] - The company has seen a significant stock price increase of 394.01% year-to-date, with a 15.50% rise in the last five trading days [1] - Huasheng Lithium Electric's main business involves the research, production, and sales of lithium battery electrolyte additives, with a revenue composition of 67.54% from VC and 27.01% from FEC [1][2] Financial Performance - For the period from January to September 2025, Huasheng Lithium Electric achieved a revenue of 539 million CNY, representing a year-on-year growth of 62.29% [2] - The company reported a net profit attributable to shareholders of -103 million CNY, showing a year-on-year increase of 21.81% [2] - Cumulative cash dividends since the A-share listing amount to 157 million CNY [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 17.25% to 12,700, with an average of 9,383 circulating shares per person, up by 62.45% [2] - Notable changes in institutional holdings include the exit of Xinhua Xin Power Flexible Allocation Mixed A and Huashan Low Carbon Life Mixed A from the top ten circulating shareholders [3]

Core Viewpoint - The company has provided details on its production capacity for lithium battery additives VC and FEC, indicating plans for future expansion and addressing the impact of raw material prices on product pricing [1] Group 1: Production Capacity - The company's subsidiary, Hankan Electronic Materials, currently has a production capacity of approximately 10,000 tons for VC and 6,500 tons for FEC [1] - There are ongoing construction projects to increase VC capacity by 5,000 tons and FEC capacity by 4,000 tons, expected to be operational in the second half of 2026 [1] - The existing precursor CEC has a production capacity of 35,000 tons per year, which can support the usage of 15,000 tons of VC and 8,000 tons of FEC [1] Group 2: Market and Pricing Dynamics - The pricing of the company's products is influenced by multiple factors, including macroeconomic conditions, industry supply and demand, competitive landscape, raw material costs, and seasonal factors [1] - The rising prices of raw materials in battery chemicals are gradually affecting the pricing of electrolytes, with the fourth quarter being a transitional phase for prices [1] - New contracts will take into account the latest raw material prices, and the efficiency of price transmission is expected to improve [1]

Group 1: Market Trends and Demand - The price of VC has rapidly increased, driven by the growth in demand for energy storage and power batteries, with current prices around 50,000 CNY/ton [2][3] - In the first half of 2025, the cumulative sales of power batteries reached 485.5 GWh, a year-on-year increase of 51.6% [3] - The shipment of lithium batteries for energy storage in China was 265 GWh in the first half of 2025, showing a year-on-year growth of 128% [3] Group 2: Production Capacity and Expansion Plans - The company currently has a production capacity of 8,000 tons/year for VC and 4,000 tons/year for FEC [4] - Plans are in place to increase VC production capacity to 10,000 tons/year by Q2 2026, with potential future expansions to 20,000 tons/year for VC and 5,000 tons/year for FEC depending on market demand [4] Group 3: Pricing and Profitability of Pharmaceutical Products - The procurement price of 6-APA has decreased by 38% compared to the end of 2024, which is expected to enhance the gross margin of the pharmaceutical manufacturing business [6] - The sales revenue from hezobactam and sulbactam is projected to account for approximately 40% of the company's total revenue in 2024 [6] Group 4: Market Outlook for Pharmaceutical Products - The sales of piperacillin-tazobactam injection exceeded 7 billion CNY in 2023, while the sales of cefoperazone-sulbactam injection surpassed 9 billion CNY, marking a year-on-year growth of 13.39% [6] - New drug approvals are expected to drive demand for upstream raw materials and intermediates, opening new growth avenues for the company [6] Group 5: Microbial Protein Production and Future Plans - The company has an existing production capacity of 1,200 tons/year for microbial protein and is accelerating the construction of a project with a planned capacity of 200,000 tons/year [9] - The microbial protein production process is efficient, sustainable, and free from antibiotics, with applications in various sectors including "meat alternatives" and health products [10] Group 6: Advantages of Amino Acid Water-Soluble Fertilizers - The amino acid water-soluble fertilizers contain essential amino acids and have shown significant effects on plant growth and metabolism [11] - The market outlook is promising due to national policies promoting the reduction of chemical fertilizers and the innovation of green inputs [11]

Core Viewpoint - The company Xinzhou Bang's subsidiary, Hankan Electronic Materials, specializes in the production of lithium battery additives, including VC and FEC, with current and future production capacities outlined [2] Group 1: Production Capacity - The current production capacity for VC is approximately 10,000 tons, with an additional 5,000 tons under construction expected to be operational by the second half of 2026 [2] - The existing production capacity for the precursor CEC is 35,000 tons per year, which can support the usage of 15,000 tons of VC and 8,000 tons of FEC [2] Group 2: Operational Status - The company's production and operational construction status is reported to be normal [2]

Group 1 - The company has a current VC production capacity of approximately 10,000 tons, with an additional 5,000 tons under construction, expected to be operational by the second half of 2026 [2] - The company's subsidiary, Hankan Electronic Materials, specializes in lithium battery additives, including VC and FEC [2] - The existing precursor CEC production capacity is 35,000 tons per year, which can support the usage of 15,000 tons of VC and 8,000 tons of FEC [2]